⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 18, 2020BMJ

How covid-19 is accelerating the threat of antimicrobial resistance

View at Publisher

Ask AI

Bookmark

Share

Abstract

Healthcare responses to the novel coronavirus may be hastening another long looming public health threat, writes Jeremy Hsu

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jeremy Hsu (2020) studied this question.

synapsesocial.com/papers/6a7f7a19fd903b7756ca794a https://doi.org/10.1136/bmj.m1983

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial PrescribingReview · 2020 · 1,655 citations
2Potential Shortages of Hydroxychloroquine for Patients with Lupus During the Coronavirus Disease 2019 PandemicOriginal Research · 2020 · 58 citations
3Antibiotic treatment for COVID-19 complications could fuel resistant bacteriaOriginal Research · 2020 · 37 citations
4ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillanceReview · 2020 · 43 citations
5Extreme weather events: A practical guide for cliniciansBMJ · Fri,

More from BMJ

Loneliness at work: We need to restore connectedness for resident doctorsFri,
Heatwaves linked with 50 000 deaths in Europe’s urban areas this summer, with climate change responsible for two thirdsFri,
Global security crisis and COP31: a duty to accelerate phasing out fossil fuelsThu,
Water shortages: how can hospitals prepare and are water companies doing enough?Thu,
Conflict and climate are compounding challenges for women’s and children’s healthWed,